Nicola Bertolino1, Michael G Dwyer1, Paul Polak1, Samuel Daniel Robinson2, Robert Zivadinov1,3, and Ferdinand Schweser1,3
1Buffalo Neuroimaging Analysis Center, Department of Neurology,Jacobs School of Medicine and Biomedical Sciences, The State University of New York at Buffalo, Buffalo, NY, United States, 2High Field Magnetic Resonance Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria, 3MRI Molecular and Translational Research Center, Jacobs School of Medicine and Biomedical Sciences, The State University of New York at Buffalo, Buffalo, NY, United States
Synopsis
FLAIR* is a
fusion of T2-FLAIR and 3D-T2*w images and it is used to assess the central-vein-sign,
a recent promising research direction in MRI-based study of Multiple Sclerosis.
However in this experiment we show that researchers should be aware that slight
patient movement during acquisition can produce blurring effect in 3D-T2*w images. This subtle artifact can mask small vessels even in case which the overall quality of the
image is not substantially degraded.INTRODUCTION
The recent observation
of central veins in MS lesions, also referred to as the central-vein-sign (CVS),
has been recognized as a promising new research direction in the MRI-based study
of Multiple Sclerosis (MS)
1. To this end, a fusion of T2-FLAIR
2 and 3D-T2* weighted (T2*w) images
3, also referred to as FLAIR*, is
commonly used to assess the relative location of veins (T2*w) and
lesions (FLAIR).
However, due to
the way k-space is sampled, 3D-sequences
are intrinsically sensitive to movements with motion artifacts that are often
not immediately apparent on the images. In particular, the visibility of small veins
on T2*w images is likely affected by motion
4, potentially
resulting in false negative or even false positive findings of the CVS. This is
problematic because patients with neurodegenerative diseases are known to have
more difficulties holding still during an MRI exam than normal controls,
potentially introducing an entirely motion-related bias into CVS-based studies.
The purpose of this
work is to study the detriment of small vein visibility on T2*w imaging caused by subtle motion. To be able to study different amounts
of motion in the same dataset, we performed a post hoc numerical simulation of head motion.
THEORY OF MOTION SIMULATION
Translations in the spatial and the Fourier domains are connected through a phase-gradient in the
respective other domain. This means that translation in the spatial domain (movement)
can be simulated by adding a linear phase gradient to the k-space.
METHODS
Data acquisition: We acquired a high-resolution dataset
from a healthy subject at 7 Tesla using a triple-echo 3D-T2*w sequence (Siemens
MAGNETOM, 32-channel coil, matrix 512×512×208, 0.32x0.32x1.2 mm3,
TE1/TR=8ms/26 ms, TA=10:17). The multi-channel data was combined using COMPOSER5.
Simulation: Our simulation assumed that translational
motion occurred in a discrete fashion between successive phase encoding steps
(TR); motion during the read-out (few ms) was neglected. We simulated four
different pseudo-random motion trajectories (M1-4;Table 1) in the transversal plane (assuming negligible axial motion) defined by three parameters: motion amplitudes in x and y directions (standard-deviation
of Gaussian distribution), respectively, and frequency of the movements.
Considering a forward sampling of k-space
(phase-1 first, then phase-2) we partitioned the k-space of the first echo image into
segments without motion and simulated different head positions
within the respective segments (movements) by adding phase
gradients to the segments.
Analysis: Two blinded raters assessed the visibility
of veins in 20 selected regions-of-interest (ROI; 80-120 mm2 ) that showed
between 0 and 3 veins on the original magnitude image. The ROIs covered in
total 26 veins. The ROIs were padded with zeros (to 512x512 pixels) and
presented to the raters in a randomized fashion, who were asked to count the
number of veins visible in every ROI. We assessed the ratings in a
self-calibrated fashion by using the presented motion-free counts as the
ground-truth of the respective rater.
RESULTS
Figure 1
illustrates exemplary slices of the original (M0) and motion corrupted (M1-4)
images along with some representative ROIs used for the blinded assessment.
Inter-rater agreement was excellent for non-motion images (M0;
3 veins difference between raters) and declined with added motion: M1: 5; M2:
3; M3: 10; M4: 4.
Figures 2 and 3
show false-negative (veins missed in
M1-4 compared to M0) and false-positive
(more veins detected in M1-4 compared to M0) detections. Both errors increased
with added motion and obtained their maximum in the most severe motion
condition (M3).
Discussion and Conclusion
Our results
indicate that even subtle sporadic motion (below 1 mm movement every 26 seconds for
a 3:50 scan, as suggested in reference 6) can result in artifacts on T2*w images that substantially degrade the visibility of small veins. The
blurring effect of the motion may be severe enough to mask the central vein in MS
lesions and thus result in an erroneous classification of a lesion as non-CVS
(false-negative). However, most importantly, the overall visible image degradation may not be severe enough to justify rejection of the scan in QA procedure (fig.1). Our results also indicate that motion
artifacts can be misinterpreted as small veins, potentially leading to
false-positive classifications.
We recommend that studies
on the CVS should account for the effect of motion on the visibility of veins. This
involves using effective means to avoid movement artifacts during the scan. In particular, research
studies need to ensure that QA of T2*w images is performed and a low
threshold is applied for rejection of a scan. Due to the difficulty in identifying subtle motion on 3D T2*w
images, ideally only groups with potentially similar motion patterns should be
compared to avoid bias.
Acknowledgements
No acknowledgement found.References
1. Campion T, Smith P, Turner B, Altmann D, Sati P, Evanson J, George I, Miquel M, Reich D and Schmierer K. FLAIR* for the non-invasive histological diagnosis of multiple sclerosis. Neurology April 6, 2015 vol. 84 no. 14 Supplement S29.003
2. Barkhof
F and Scheltens P Imaging of White Matter Lesions. Cerebrovasc Dis
2002;13(suppl 2):21–30
3. Reichenbach
JR, Venkatesan R, Shillinger DJ, Kido DK, Hacke EM. Small vessels in human
brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent.
Radiology 1997; 204(1):272-277.
4. Reuter
M, Tisdall MD, Quereshi A, Buckner RL, Van der Kouwe AJW and Fischl B. Head
motion during MRI acquisition reduces gray matter volume and thickness
estimates. NeuroImage, Volume 107, 15 February 2015, Pages 107–115
5. Robinson SD, Bogner W, Dymerska B, Cardoso P, Grabner G, Deligianni X, Bieri O, Trattnig S. COMbining Phased array data using Offsets from a Short Echo-time Reference scan (COMPOSER). Proceedings of the Twenty-forth Annual Meeting of the ISMRM, Toronto. 2015: #3308
6. Sati
P, George IC, Shea CD, Gaitán MI and Reich DS. FLAIR*: A Combined MR Contrast
Technique for Visualizing White Matter Lesions and Parenchymal Veins.
Radiology, December 2012, volume 265, issue 3.